Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies (Q36579186)
Jump to navigation
Jump to search
scientific article published on 9 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies |
scientific article published on 9 December 2011 |
Statements
1 reference
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies (English)
1 reference
Glen J Weiss
1 reference
Mitesh J Borad
1 reference
Daniel Laheru
1 reference
Raoul Tibes
1 reference
Ramesh K Ramanathan
1 reference
Lisa Blaydorn
1 reference
Gayle Jameson
1 reference
Antonio Jimeno
1 reference
Jeffrey D Isaacs
1 reference
Angela Scaburri
1 reference
Maria Adele Pacciarini
1 reference
Francesco Fiorentini
1 reference
Marina Ciomei
1 reference
Daniel D Von Hoff
1 reference
9 December 2011
1 reference
1 reference
2334-2343
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference